Document Details

  • Form: 4
  • Filing Date: March 2, 2020
  • Document Date: February 27, 2020
  • Form Description: Statement of changes in beneficial ownership of securities
  • Filing Group: 3-4-5
  • Company: Verrica Pharmaceuticals
  • Filer: DAVIS A BRIAN

Filing Formats

About Us
Our Medicines
Product Candidates
Investors & Media
Careers
Twitter Linkedin-in Facebook-f
© 2023 Verrica Pharmaceuticals.

VIRTUAL KOL EVENT

Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution for the Treatment of Molluscum

October 11th, 2023 | 11:00 AM ET

Click to Register & Attend